Candriam Luxembourg S.C.A. »

Catalyst Pharmaceutical Partners shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.8M 56k 31.40
2017-09-30 $1.4M 560k 2.52
2017-06-30 $1.5M 560k 2.76
2017-03-31 $1.2M 600k 1.95

More positions owned by Candriam Luxembourg S.C.A.

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Palo Alto Networks (PANW)
Lam Research Corp Com New (LRCX)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Kla Corp Com New (KLAC)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
State Street Corporation
American Century Companies
Vanguard Capital Management
Dimensional Fund Advisors
Glazer Capital
Jpmorgan Chase & Co
Geode Capital Management
HBK Investments
Morgan Stanley
Vanguard Portfolio Management
Jupiter Topco
Qube Research & Technologies
Renaissance Technologies
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners